Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Bioptix discloses on Mar 10 the co sold $2.25 mln units of securities at $2.50/unit, consists of 1 share & a 3-year warrant to purchase 1 share of stock at $3.50/share; on Mar 15 co also agreed to sell up to $4.75 mln promissory notes & 3-year warrants (3.56)<ul><li><strong>Placement of units:</strong><ul><li>The warrants are exercisable, at any time on or after the sixth month anniversary of the closing date of the private placement, at a price of $3.50 per share, subject to adjustment, and expire three years from the date of issuance. The holders may, subject to certain limitations, exercise the Warrants on a cashless basis. the company is prohibited from effecting an exercise of any warrant to the extent that, as a result of any such exercise, the holder would beneficially own more than 9.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of shares of common stock upon exercise of such warrant.</li></ul></li><li><strong>Placement of notes:</strong><ul><li>The notes shall be issued to each note investor in such note investor's subscription amount and shall be convertible into shares of common stock at an initial conversion price of $2.50. Each purchase warrant shall be exercisable into shares of common stock at an exercise price equal to $3.56 per share.</li></ul></li></ul></td> </tr></table>"